Long-term follow-up of macular translocation with 360° retinotomy for exudative age-related macular degeneration

Archives of Ophthalmology

Volumn 125, Issue 10, 2007, Pages 1367-1372

  Aisenbrey, Sabine ^a   Bartz Schmidt, Karl Ulrich ^a   Walter, Peter ^b   Hilgers, Ralf Dieter ^b   Ayertey, Helen ^c   Szurman, Peter ^a   Thumann, Gabriele ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; RETINOTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

ATROPHY; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE COMPLICATIONS; MACULA LUTEA; MACULAR DEGENERATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; PIGMENT EPITHELIUM OF EYE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 35348979237     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.10.1367     Document Type: Article

References (19)

1. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1994;112(4):480-488.
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials, TAP report 1. Arch Ophthalmol. 1999;117(10):1329-1345.
3. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; D'Amico DJ, Masonson HN, Patel M, et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology. 2006;113(6):992-1001.e6.
4. Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113(4):642.el.
5. Aisenbrey S, Lafaut BA, Szurman P, et al. Iris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-up. Arch Ophthalmol. 2006;124(2):183-188.
6. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45(11):4151-4160.
7. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112(12):2081-2087.
8. Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142(1):17-30.
9. Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol. 1996;122(5):613-621.
10. Eckardt C, Eckardt U, Conrad HJ. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237(4):313-325.
11. Lewis H, Kaiser P, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol. 1999;128(2):135-146.
12. Akduman L, Karavellas M, MacDonald C, Olk J, Freeman W. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. Retina. 1999;19(5):418-423.
13. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360° retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002;120(4):451-459.
14. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age-related macular degeneration. Br J Ophthalmol. 2003;87(5):615-621.
15. Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360° retinectomy for neovascular age-related macular degeneration. Ophthalmology. 2004;111(9):1715-1724.
16. Bressler NM, Bressler SB, Childs AL, et al; Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings, SST report No. 13. Ophthalmology. 2004;111(11):1993-2006.
17. Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360° peripheral retinectomy for geographic atrophy. Arch Ophthalmol. 2005;123(7):935-938.
18. Khurana RN, Fujii GY, Walsh AC, Humayun MS, de Juan E, Sadda SR. Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration. Ophthalmology. 2005;112(9):1586-1591.
19. Wong D, Stanga P, Briggs M, et al. Case selection in macular relocation surgery for age-related macular degeneration. Br J Ophthalmol. 2004;88(2):186-190.